Melatonin Pharma Nord (Melatonin)

Melatonin works by binding to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus. This activation mimics the natural hormone released at night, signaling the body that it is time to sleep, reducing neuronal activity, and helping to synchronize internal clocks with external light‑dark cycles.

The appropriate dose of Melatonin Pharma Nord is determined by a prescriber based on the individual’s age, condition, and response to therapy. Healthcare professionals tailor the regimen to achieve the desired sleep‑promoting effect while minimizing potential side effects.

Safety of melatonin in pregnancy and lactation has not been definitively established. It should only be used if the prescribing clinician judges that the potential benefit outweighs any possible risk to the mother or infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Melatonin differs from traditional sedative hypnotics such as benzodiazepines or Z‑drugs because it acts on physiological sleep‑regulating pathways rather than producing broad CNS depression. It is generally associated with fewer next‑day residual effects, but its efficacy may be limited to circadian‑related sleep disturbances.

Melatonin Pharma Nord should be stored at ambient temperature below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct light, and ensure the container is tightly closed to maintain product stability.

The product is taken orally, usually with a glass of water. It is commonly administered 30–60 minutes before the intended bedtime, but the exact timing and frequency should follow the prescribing clinician’s instructions.

Serious but rare risks include severe allergic reactions such as anaphylaxis, significant mood alterations like depression or irritability, and hormonal disturbances that may affect menstrual cycles. Patients should seek immediate medical attention if they experience any signs of a severe reaction.

Melatonin should be avoided in individuals with known hypersensitivity to melatonin or any excipients in the formulation, in patients with uncontrolled severe depression, and in those for whom the prescriber determines that the risks outweigh the benefits, such as certain pregnant or breastfeeding women.